← FDA Drug Approvals (Drugs@FDA)

BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS TEVA · Approved 2000-09-25

Drug application

FDA Application #

ANDA075469

Application type

Abbreviated New Drug Application (Generic)

Brand name

BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE

Generic name

Bisoprolol Fumarate

Active ingredients

BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

WATSON LABS TEVA

First approval

2000-09-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown